论文信息 - A Phase 2 Randomized, Double-Blind, Placebo-controlled Trial of Oral Camostat Mesylate for Early Treatment of COVID-19 Outpatients Showed Shorter Illness Course and Attenuation of Loss of Smell and Taste - 字舞流文

A Phase 2 Randomized, Double-Blind, Placebo-controlled Trial of Oral Camostat Mesylate for Early Treatment of COVID-19 Outpatients Showed Shorter Illness Course and Attenuation of Loss of Smell and Taste

G. Desir | J. Dziura | S. Halene | K. Patra | J. Vinetz | Geliang Gan | L. Danzig | L. Katsovich | O. Søgaard | Fangyong Li | Jianhui Wang | P. Hui | R. Chaurasia | Amisha Patel | Anne Spichler-Moffarah | D. Esserman | Jeanine May | G. Chupp | Aryeh Salovey | P. Patel | Angela Nunez | Lauren Astorino | Jing Lu | Stephen D. Parziale